查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1576806

基因轉移技術市場：按類型、應用、最終用戶、適應症分類 - 全球預測 2025-2030

Gene Delivery Technologies Market by Type (Non-Viral Vector, Viral Vector), Application (Cell Therapy, Gene Therapy, Research), End User, Disease Indication - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年基因轉移技術市場價值為43.4億美元，預計到2024年將達到49.4億美元，複合年成長率為14.82%，到2030年將達到114.3億美元。

基因轉移技術涉及將遺傳物質引入細胞以修改基因表現、修復缺陷基因和增強免疫反應的方法和機制。這項技術對於基因治療的進步至關重要，基因治療旨在透過針對基因的根源來治療或預防疾病。基因轉殖的主要應用包括治療遺傳疾病、癌症和感染疾病，並在疫苗開發中發揮越來越大的作用。最終用途包括製藥和生物技術公司、研究和學術機構以及專注於先進基因治療的醫療機構。

主要市場統計
基準年[2023] 43.4億美元
預測年份 [2024] 49.4億美元
預測年份 [2030] 114.3億美元
複合年成長率（%） 14.82%

市場成長受到遺傳疾病日益普及、基因組學進步以及對標靶治療需求迅速增加的影響。一個主要的商機在於開發非病毒傳遞系統，該系統可以減輕病毒載體引起的免疫反應並提高患者的安全。抓住這些機會的研究包括投資新的給藥系統和個人化醫療方法的研究、與研究機構建立策略夥伴關係以及擴大臨床試驗網路。該市場還面臨高昂的開發成本、嚴格的法律規範以及基因改造的倫理問題等限制。此外，在不引起副作用的情況下有效遞送至目標細胞的技術挑戰也構成了主要障礙。

研究和創新將致力於提高遞送系統的功效和安全性、開發靶向奈米顆粒載體以及利用 CRISPR 技術進行精確基因組編輯。找到這些挑戰的解決方案可以帶來顯著的業務成長，特別是在個人化醫療和免疫療法領域。基因轉移技術市場的本質是高度動態的，其基礎是不斷的技術進步和不斷變化的監管環境。利用基因組編輯和遞送方法的尖端研究的公司可能會透過提供滿足未滿足的醫療需求的創新解決方案而處於領先地位，從而確保在這個快速發展的領域的競爭優勢。

市場動態：揭示快速發展的基因轉移技術市場的關鍵市場洞察

基因轉移技術市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 擴大農業和獸醫領域的應用
    • 學術機構與生物製藥公司合作開發創新解決方案
    • 政府對基因治療進展的承諾和監管支持
    • 用於有效基因轉移的新型病毒和非病毒載體的出現
  • 市場限制因素
    • 實現治療基因高效、標靶化遞送的技術挑戰
    • 基因轉移技術的專家和專業知識數量有限
  • 市場機會
    • 創新基因轉殖方法治療罕見遺傳疾病取得重大進展
    • 開發非病毒載體以實現抑制免疫反應的更安全基因治療的巨大潛力
    • 擴大基因治療在黃斑部病變和關節炎等老齡化疾病的應用
  • 市場挑戰
    • 高開發成本及研發投資影響基因轉殖技術市場
    • 基因轉移領域的智慧財產權和專利挑戰影響市場動態

波特五力：駕馭基因轉殖技術市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解基因轉移技術市場的外部影響

外部宏觀環境因素在塑造基因轉移技術市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解基因轉殖技術市場的競爭狀況

對基因轉移技術市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣基因轉殖技術市場供應商績效評估

FPNV定位矩陣是評估基因轉殖技術市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了基因轉移技術市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對基因轉移技術市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 擴大應用到農業和獸醫領域
      • 合作學術機構和生物製藥公司提供創新解決方案
      • 政府對基因治療進展的承諾和監管支持
      • 用於有效基因傳遞的新型病毒和非病毒載體的出現
    • 抑制因素
      • 實現治療基因高效、標靶遞送的技術挑戰
      • 基因轉移技術的熟練專業人員和專業知識有限
    • 機會
      • 創新基因遞送方法為罕見遺傳疾病治療取得重大突破
      • 開發非病毒載體以實現更安全的限制免疫反應的基因治療具有巨大潛力
      • 擴大基因治療在老齡化疾病（如老齡化黃斑部病變和關節炎）的應用
    • 任務
      • 基因轉殖技術市場受高開發成本及研發投入影響
      • 基因傳遞領域的智慧財產權和專利挑戰影響市場動態
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 基因轉殖技術市場：依類型

  • 非病毒載體
    • 化學法
      • 脂質體
      • 聚合物基
    • 物理方法
      • 電穿孔
      • 顯微注射
      • 粒子撞擊
  • 病毒載體
    • 腺結合病毒
    • 腺病毒
    • 慢病毒
    • 逆轉錄病毒

第7章 基因轉殖技術市場：依應用分類

  • 細胞療法
  • 基因治療
    • 單基因疾病
    • 多基因疾病
  • 調查
  • 疫苗
    • 細菌疫苗
    • 病毒疫苗

第8章 基因轉殖技術市場：依最終使用者分類

  • 生技公司
  • 合約調查機構
  • 製藥公司
  • 調查機構

第9章基因轉殖技術市場：依疾病適應症

  • 癌症
  • 心血管疾病
  • 遺傳疾病
    • 囊腫纖維化
    • 肌肉萎縮症
  • 感染疾病

第10章 北美和南美基因轉殖技術市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區基因轉殖技術市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲基因轉殖技術市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-1A1A064C021C

The Gene Delivery Technologies Market was valued at USD 4.34 billion in 2023, expected to reach USD 4.94 billion in 2024, and is projected to grow at a CAGR of 14.82%, to USD 11.43 billion by 2030.

Gene delivery technologies involve the methods and mechanisms through which genetic material is introduced into cells to modify gene expression, repair defective genes, or bolster the immune response. This technology is essential in the advancement of gene therapy, which aims to treat or prevent diseases by targeting their genetic roots. The main applications of gene delivery include the treatment of genetic disorders, cancer, and infectious diseases, with an expanding role in vaccine development. The end-use scope comprises pharmaceutical and biotechnology companies, research and academic institutions, and healthcare facilities focused on advanced genetic treatments.

KEY MARKET STATISTICS
Base Year [2023] USD 4.34 billion
Estimated Year [2024] USD 4.94 billion
Forecast Year [2030] USD 11.43 billion
CAGR (%) 14.82%

Market growth is influenced by the increasing prevalence of genetic disorders, advancements in genomics, and a surge in demand for targeted therapies. A significant opportunity lies in the development of non-viral delivery systems, which mitigate immune responses induced by viral vectors and enhance patient safety. Recommendations for capturing these opportunities include investing in research for novel delivery systems and personalized medicine approaches, forming strategic partnerships with research institutions, and expanding clinical trial networks. The market also faces limitations, such as high development costs, stringent regulatory frameworks, and ethical concerns regarding genetic modifications. Moreover, the technical challenges in effective delivery to target cells without inducing adverse reactions pose significant hurdles.

Research and innovation can be directed towards improving the efficacy and safety of delivery systems, developing targeted nanoparticle carriers, and utilizing CRISPR technology for precise genome editing. Uncovering solutions for these challenges could result in substantial business growth, particularly in personalized medicine and immunotherapy sectors. The nature of the gene delivery technology market is highly dynamic, underscored by constant technological progress and evolving regulatory landscapes. Businesses that leverage cutting-edge research in genome editing and delivery methodologies are likely to lead in providing transformative solutions that meet unmet medical needs, thus ensuring a competitive edge in this rapidly advancing field.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gene Delivery Technologies Market

The Gene Delivery Technologies Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Expansion of applications in agriculture and veterinary sciences
    • Collaboration between academic institutions and biopharmaceutical companies for innovative solutions
    • Government initiatives and regulatory support for gene therapy advancements
    • Emergence of novel viral and non-viral vectors for efficient gene delivery
  • Market Restraints
    • Technical challenges in achieving efficient and targeted delivery of therapeutic genes
    • Limited availability of skilled professionals and expertise in gene delivery technologies
  • Market Opportunities
    • Innovative gene delivery methods for rare genetic disorder treatments showing significant advancements
    • High potential in developing non-viral vectors for safer gene therapies limiting immune responses
    • Expanding gene therapy applications for age-related conditions such as macular degeneration and arthritis
  • Market Challenges
    • High development costs and R&D investments impacting gene delivery technologies market
    • Intellectual property and patent challenges in the gene delivery space affecting market dynamics

Porter's Five Forces: A Strategic Tool for Navigating the Gene Delivery Technologies Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gene Delivery Technologies Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gene Delivery Technologies Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gene Delivery Technologies Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gene Delivery Technologies Market

A detailed market share analysis in the Gene Delivery Technologies Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gene Delivery Technologies Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gene Delivery Technologies Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gene Delivery Technologies Market

A strategic analysis of the Gene Delivery Technologies Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gene Delivery Technologies Market, highlighting leading vendors and their innovative profiles. These include Amgen, Avalanche Biotechnologies, Beam Therapeutics, BioNTech, Bluebird Bio, CRISPR Therapeutics, Editas Medicine, GlaxoSmithKline, Intellia Therapeutics, Moderna Therapeutics, Novartis, Pfizer, REGENXBIO, Roche, Sangamo Therapeutics, Sanofi, Spark Therapeutics, uniQure, Voyager Therapeutics, and Ziopharm Oncology.

Market Segmentation & Coverage

This research report categorizes the Gene Delivery Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Non-Viral Vector and Viral Vector. The Non-Viral Vector is further studied across Chemical Methods and Physical Methods. The Chemical Methods is further studied across Liposomes and Polymer Based. The Physical Methods is further studied across Electroporation, Microinjection, and Particle Bombardment. The Viral Vector is further studied across Adeno-Associated Virus, Adenovirus, Lentivirus, and Retrovirus.
  • Based on Application, market is studied across Cell Therapy, Gene Therapy, Research, and Vaccines. The Gene Therapy is further studied across Monogenic Disorders and Multigenic Disorders. The Vaccines is further studied across Bacterial Vaccines and Viral Vaccines.
  • Based on End User, market is studied across Biotechnological Companies, Contract Research Organizations, Pharmaceutical Companies, and Research Institutes.
  • Based on Disease Indication, market is studied across Cancer, Cardiovascular Diseases, Genetic Disorders, and Infectious Diseases. The Genetic Disorders is further studied across Cystic Fibrosis and Muscular Dystrophy.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Expansion of applications in agriculture and veterinary sciences
      • 5.1.1.2. Collaboration between academic institutions and biopharmaceutical companies for innovative solutions
      • 5.1.1.3. Government initiatives and regulatory support for gene therapy advancements
      • 5.1.1.4. Emergence of novel viral and non-viral vectors for efficient gene delivery
    • 5.1.2. Restraints
      • 5.1.2.1. Technical challenges in achieving efficient and targeted delivery of therapeutic genes
      • 5.1.2.2. Limited availability of skilled professionals and expertise in gene delivery technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovative gene delivery methods for rare genetic disorder treatments showing significant advancements
      • 5.1.3.2. High potential in developing non-viral vectors for safer gene therapies limiting immune responses
      • 5.1.3.3. Expanding gene therapy applications for age-related conditions such as macular degeneration and arthritis
    • 5.1.4. Challenges
      • 5.1.4.1. High development costs and R&D investments impacting gene delivery technologies market
      • 5.1.4.2. Intellectual property and patent challenges in the gene delivery space affecting market dynamics
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Gene Delivery Technologies Market, by Type

  • 6.1. Introduction
  • 6.2. Non-Viral Vector
    • 6.2.1. Chemical Methods
      • 6.2.1.1. Liposomes
      • 6.2.1.2. Polymer Based
    • 6.2.2. Physical Methods
      • 6.2.2.1. Electroporation
      • 6.2.2.2. Microinjection
      • 6.2.2.3. Particle Bombardment
  • 6.3. Viral Vector
    • 6.3.1. Adeno-Associated Virus
    • 6.3.2. Adenovirus
    • 6.3.3. Lentivirus
    • 6.3.4. Retrovirus

7. Gene Delivery Technologies Market, by Application

  • 7.1. Introduction
  • 7.2. Cell Therapy
  • 7.3. Gene Therapy
    • 7.3.1. Monogenic Disorders
    • 7.3.2. Multigenic Disorders
  • 7.4. Research
  • 7.5. Vaccines
    • 7.5.1. Bacterial Vaccines
    • 7.5.2. Viral Vaccines

8. Gene Delivery Technologies Market, by End User

  • 8.1. Introduction
  • 8.2. Biotechnological Companies
  • 8.3. Contract Research Organizations
  • 8.4. Pharmaceutical Companies
  • 8.5. Research Institutes

9. Gene Delivery Technologies Market, by Disease Indication

  • 9.1. Introduction
  • 9.2. Cancer
  • 9.3. Cardiovascular Diseases
  • 9.4. Genetic Disorders
    • 9.4.1. Cystic Fibrosis
    • 9.4.2. Muscular Dystrophy
  • 9.5. Infectious Diseases

10. Americas Gene Delivery Technologies Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Gene Delivery Technologies Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Gene Delivery Technologies Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amgen
  • 2. Avalanche Biotechnologies
  • 3. Beam Therapeutics
  • 4. BioNTech
  • 5. Bluebird Bio
  • 6. CRISPR Therapeutics
  • 7. Editas Medicine
  • 8. GlaxoSmithKline
  • 9. Intellia Therapeutics
  • 10. Moderna Therapeutics
  • 11. Novartis
  • 12. Pfizer
  • 13. REGENXBIO
  • 14. Roche
  • 15. Sangamo Therapeutics
  • 16. Sanofi
  • 17. Spark Therapeutics
  • 18. uniQure
  • 19. Voyager Therapeutics
  • 20. Ziopharm Oncology

LIST OF FIGURES

  • FIGURE 1. GENE DELIVERY TECHNOLOGIES MARKET RESEARCH PROCESS
  • FIGURE 2. GENE DELIVERY TECHNOLOGIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. GENE DELIVERY TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. GENE DELIVERY TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENE DELIVERY TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENE DELIVERY TECHNOLOGIES MARKET DYNAMICS
  • TABLE 7. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY LIPOSOMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY POLYMER BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY MICROINJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PARTICLE BOMBARDMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY ADENO-ASSOCIATED VIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY ADENOVIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY LENTIVIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY RETROVIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY MONOGENIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY MULTIGENIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY BACTERIAL VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY BIOTECHNOLOGICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY MUSCULAR DYSTROPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 80. BRAZIL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. BRAZIL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. BRAZIL GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. CANADA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 90. CANADA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 91. CANADA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. CANADA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. CANADA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. MEXICO GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 96. MEXICO GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 98. MEXICO GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 99. MEXICO GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. MEXICO GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 101. MEXICO GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 102. MEXICO GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. MEXICO GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. MEXICO GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 108. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 109. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 110. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 112. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 113. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 115. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 116. UNITED STATES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. AUSTRALIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 132. AUSTRALIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 134. AUSTRALIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 136. AUSTRALIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 137. AUSTRALIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. AUSTRALIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 140. CHINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. CHINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 142. CHINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 143. CHINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 144. CHINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 145. CHINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. CHINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 147. CHINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 148. CHINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. CHINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 150. CHINA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 151. INDIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. INDIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 153. INDIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 154. INDIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 155. INDIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 156. INDIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. INDIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 158. INDIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 159. INDIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. INDIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 161. INDIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 162. INDONESIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. INDONESIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 164. INDONESIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 165. INDONESIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 166. INDONESIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 167. INDONESIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. INDONESIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 169. INDONESIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 170. INDONESIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. INDONESIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. INDONESIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 173. JAPAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. JAPAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 175. JAPAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 176. JAPAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 177. JAPAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 178. JAPAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. JAPAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 180. JAPAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 181. JAPAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. JAPAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 183. JAPAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 184. MALAYSIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. MALAYSIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 186. MALAYSIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 187. MALAYSIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 188. MALAYSIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 189. MALAYSIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. MALAYSIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 191. MALAYSIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 192. MALAYSIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. MALAYSIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 194. MALAYSIA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. PHILIPPINES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 198. PHILIPPINES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 199. PHILIPPINES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 200. PHILIPPINES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. PHILIPPINES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 202. PHILIPPINES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 203. PHILIPPINES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 204. PHILIPPINES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 205. PHILIPPINES GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 206. SINGAPORE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SINGAPORE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 208. SINGAPORE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 209. SINGAPORE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 210. SINGAPORE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 211. SINGAPORE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SINGAPORE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 213. SINGAPORE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 214. SINGAPORE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 215. SINGAPORE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 216. SINGAPORE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 217. SOUTH KOREA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SOUTH KOREA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 219. SOUTH KOREA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 220. SOUTH KOREA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 221. SOUTH KOREA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 222. SOUTH KOREA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. SOUTH KOREA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 224. SOUTH KOREA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 225. SOUTH KOREA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 226. SOUTH KOREA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 227. SOUTH KOREA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 228. TAIWAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. TAIWAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 230. TAIWAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 231. TAIWAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 232. TAIWAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 233. TAIWAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. TAIWAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 235. TAIWAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 236. TAIWAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. TAIWAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 238. TAIWAN GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 239. THAILAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. THAILAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 241. THAILAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 242. THAILAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 243. THAILAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 244. THAILAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. THAILAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 246. THAILAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 247. THAILAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 248. THAILAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 249. THAILAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 250. VIETNAM GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. VIETNAM GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 252. VIETNAM GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 253. VIETNAM GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 254. VIETNAM GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 255. VIETNAM GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. VIETNAM GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 257. VIETNAM GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 258. VIETNAM GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 259. VIETNAM GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 260. VIETNAM GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 273. DENMARK GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. DENMARK GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 275. DENMARK GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 276. DENMARK GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 277. DENMARK GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 278. DENMARK GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 279. DENMARK GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 280. DENMARK GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 281. DENMARK GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 282. DENMARK GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 283. DENMARK GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 284. EGYPT GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 285. EGYPT GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 286. EGYPT GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 287. EGYPT GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 288. EGYPT GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 289. EGYPT GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 290. EGYPT GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 291. EGYPT GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 292. EGYPT GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 293. EGYPT GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 294. EGYPT GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 295. FINLAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 296. FINLAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 297. FINLAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 298. FINLAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 299. FINLAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 300. FINLAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 301. FINLAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 302. FINLAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 303. FINLAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 304. FINLAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 305. FINLAND GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 306. FRANCE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 307. FRANCE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 308. FRANCE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 309. FRANCE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 310. FRANCE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 311. FRANCE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 312. FRANCE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENE THERAPY, 2018-2030 (USD MILLION)
  • TABLE 313. FRANCE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
  • TABLE 314. FRANCE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 315. FRANCE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 316. FRANCE GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY GENETIC DISORDERS, 2018-2030 (USD MILLION)
  • TABLE 317. GERMANY GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 318. GERMANY GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY NON-VIRAL VECTOR, 2018-2030 (USD MILLION)
  • TABLE 319. GERMANY GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY CHEMICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 320. GERMANY GENE DELIVERY TECHNOLOGIES MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 321. GERMANY GEN